LifeMD to Report First Quarter 2025 Financial Results on May 6
LifeMD (Nasdaq: LFMD), a virtual primary care services provider, has scheduled its Q1 2025 financial results announcement for May 6, 2025, after U.S. market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LifeMD (Nasdaq: LFMD), a virtual primary care services provider, has scheduled its Q1 2025 financial results announcement for May 6, 2025, after U.S. market close.
The company will host a conference call and webcast at 4:30 p.m. Eastern time to discuss the results for the three months ended March 31, 2025. Interested parties can join through multiple channels:
- Toll-Free: 800-225-9448
- International: 203-518-9708
- Conference ID: LIFEMD
A live webcast will be available, and an archived version will be accessible for replay after the event.
Details
News Market Reaction – LFMD
The recorded move for LFMD in the trading session of this news was +41.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on May 6, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time.
Conference Call & Webcast Details
| Date: | Tuesday, May 6th |
| Time: | 4:30 p.m. Eastern time |
| Toll-Free Dial-In: | 800-225-9448 |
| International Dial-In: | 203-518-9708 |
| Conference ID: | LIFEMD |
| Live & Archived Webcast: | Link |
About LifeMD, Inc.
LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.